SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex Inc. ($CETX) is trending due to high volatility and significant pre-market price movement, reminiscent of recent low-float runners. The community is actively discussing the stock's multiple trading halts, potential manipulation, and whether it can sustain its momentum. Some traders are drawing comparisons to past short squeezes, while others caution against chasing the pump.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Recent deal speculation involving $NFLX and $WBD has triggered volatility, with community members actively debating the potential outcomes and regulatory hurdles. Discussion centers on the financial implications of a potential acquisition, including debt concerns and shareholder value. Competing bids and potential government intervention add further uncertainty, driving both bullish and bearish sentiment.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

Treasure Global ($TGL) is trending due to renewed community excitement around its potential for a short squeeze, drawing comparisons to similar plays like $SMX. Bullish investors are encouraged by high borrow rates and a perceived lack of available shares for shorting, while others point to a recent revenue target update as a positive catalyst.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences ($WVE) is trending as community members discuss its recent surge potentially driven by promising data and analyst upgrades, although a new public offering announcement has sparked mixed reactions. Bullish sentiment highlights the potential of WVE's technology and pipeline, while others caution about dilution and potential pullbacks. Some traders speculate on short squeeze potential and the stock's long-term prospects in the weight loss and RNA editing space.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending as investors discuss its potential S&P 500 inclusion and the implications for its valuation. Community members are debating whether the stock is overvalued, citing the company's business model and debt, while others point to institutional ownership and potential for further gains. The stock's impressive comeback and potential for a short squeeze are also key talking points.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending due to speculation of a potential short squeeze, drawing comparisons to recent low-float runners like $SMX and $TGL. The stock's low float and high short interest are fueling community discussions about a potential breakout, with traders actively monitoring price levels and anticipating a surge in volume. Some traders are expressing caution, citing past dilution and the stock's history, while others see significant upside potential.

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.

Structure Therapeutics Inc - ADR

GPCR is trending as community members discuss the potential of its oral obesity drug, particularly after positive mid-stage study results that position it as a challenger to injectable treatments. Community sentiment is bullish, with some drawing comparisons to other high-flying stocks and speculating on future price targets. Some caution is warranted regarding safety data, but overall, the community sees potential for significant gains due to a cheap market cap and best-in-class potential.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to a projected profit turnaround for FY25, sparking interest in its low float and potential for a significant squeeze similar to other recent runners. The community is closely watching for breakout opportunities and debating its potential to reach higher price targets. Keep an eye on this stock as traders look to capitalize on its momentum.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid a potential acquisition battle, with Paramount Skydance launching a hostile bid and community members weighing the pros and cons of offers from Paramount versus Netflix. Community discussion revolves around which deal is more beneficial for shareholders, with regulatory hurdles and debt loads being key concerns. The potential deal has sparked broader debate about the future of streaming and media consolidation.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

PSKY is trending amid ongoing speculation about a potential acquisition of WBD, with community chatter focusing on whether Paramount will increase its offer. Some believe a deal with Warner Bros. is essential for Paramount's survival, while others suggest focusing on organic growth and existing assets like the UFC partnership. Discussions also involve potential regulatory hurdles and the possibility of a hostile takeover bid.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SEPN Bullish (8.2) 
 
Looking good for tomorrow. 
 
In the latest analysis of Septerna, Inc. 
(SEPN), the company exhibits strong momentum, reflected by a significant 53% increase in share price over the past month and nearly doubling its value in the last quarter. 
The recent appointment of Dr. 
Keith Gottesdiener to the board has generated optimism due to his extensive experience in drug development. 
This strategic leadership change is expected to enhance the company&#39;s focus on G protein-coupled receptor (GPCR) drug discovery, a promising area within biotechnology. 
Financially, Septerna&#39;s P/E ratio remains competitive within the biotech sector, and while specific EPS growth figures are not disclosed, the upward price movement suggests positive investor sentiment regarding future earnings. 
Revenue forecasts appear to be optimistic, although current trends in earnings estimate revisions indicate some caution. 
Comparatively, SEPN is performing well against industry peers, bolstered by insider buying activity that has increased by 219%, signaling confidence from those closest to the company. 
Looking ahead, Septerna is set to report earnings in the near future. 
Analysts are closely monitoring these upcoming results, given the historical performance of the company, which has shown volatility but also potential for significant upside. 
The consensus among analysts is cautiously optimistic, with estimates suggesting a modest increase in revenue driven by ongoing clinical trials and potential product advancements. 
The impact of these earnings reports could be substantial, particularly if the company can demonstrate progress in its drug pipeline and articulate a clear growth strategy. 
In terms of sector performance, the biotechnology sector has shown resilience, with many companies experiencing robust growth driven by innovation and increased market demand for new therapies. 
As SEPN operates within this dynamic environment, its recent developments and strategic initiatives position it favorably for continued growth amidst sector-wide advancements.

StockTwits Web

Septerna Inc.

 Bullish (8.2) 
 
Looking good for tomorrow. 
 
In the latest analysis of Septerna, Inc. 
(SEPN), the company exhibits strong momentum, reflected by a significant 53% increase in share price over the past month and nearly doubling its value in the last quarter. 
The recent appointment of Dr. 
Keith Gottesdiener to the board has generated optimism due to his extensive experience in drug development. 
This strategic leadership change is expected to enhance the company's focus on G protein-coupled receptor (GPCR) drug discovery, a promising area within biotechnology. 
Financially, Septerna's P/E ratio remains competitive within the biotech sector, and while specific EPS growth figures are not disclosed, the upward price movement suggests positive investor sentiment regarding future earnings. 
Revenue forecasts appear to be optimistic, although current trends in earnings estimate revisions indicate some caution. 
Comparatively, SEPN is performing well against industry peers, bolstered by insider buying activity that has increased by 219%, signaling confidence from those closest to the company. 
Looking ahead, Septerna is set to report earnings in the near future. 
Analysts are closely monitoring these upcoming results, given the historical performance of the company, which has shown volatility but also potential for significant upside. 
The consensus among analysts is cautiously optimistic, with estimates suggesting a modest increase in revenue driven by ongoing clinical trials and potential product advancements. 
The impact of these earnings reports could be substantial, particularly if the company can demonstrate progress in its drug pipeline and articulate a clear growth strategy. 
In terms of sector performance, the biotechnology sector has shown resilience, with many companies experiencing robust growth driven by innovation and increased market demand for new therapies. 
As SEPN operates within this dynamic environment, its recent developments and strategic initiatives position it favorably for continued growth amidst sector-wide advancements.